|
|
||||||||
Published online before print July 28, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Department of Host Defense and Biochemical Research, Juntendo University School of Medicine, Tokyo, Japan; and
Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
1 Correspondence: Department of Host Defense and Biochemical Research, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. E-mail: someya{at}med.juntendo.ac.jp
We previous identified adenosine 5'-diphosphate-ribosylation factor (ARF)-guanine nucleotide-exchange protein, 100 kDa (GEP100), as a novel GEP with a molecular size of
100 kDa, which preferentially activates ARF6. In this study, we examined the effect of ARF-GEP100 on monocytic cell apoptosis. Overexpression of ARF-GEP100 in PMA-differentiated human monocyte-macrophage-like U937 cells and mouse macrophage RAW264.7 cells induced apoptotic cell death, which was detected by morphological changes (chromatin condensation, nucleus fragmentation, and shrinking of cytoplasm), annexin V-staining, and TUNEL assay. It is interesting that a mutant lacking the Sec7 domain, which is responsible for ARF activation, was able to induce apoptosis of the target cells to the level of that of a wild-type ARF-GEP100. Furthermore, ARF-GEP100-silencing experiments indicated that the TNF-
-induced apoptosis was significantly suppressed among ARF-GEP100-depressed cells. These observations apparently suggest that ARF-GEP100 is involved in the induction of apoptosis in monocytic phagocytes, possibly independent of ARF activation.
Key Words: apoptosis GEF Sec7 domain macrophages siRNA
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |